Table 2.

Patients presenting confirmed GVHD

Pt#	Type ITx	Sex	Donor sex	Donor BM	Site of GVHD	Presentation (Post-ITx days)	Grade GVHD*	Flow cytometry at symptoms** (Post-ITx days)	Flow cytometry follow-up** (Post-ITx days)
1	L/SB/P	M	M	N	Skin	24	I	16.1 (21)	2.5 (62)
2	L/SB/P	M	M	N	Skin	23	I	14.1 (20)	6.7 (64)
3	SB	F	M	N	Skin	60	II	0.9 (27)	3.5(47)/15(61)
4	SB	M	F	N	Skin	30	I	6.8 (52)	ND

^*Histologic classification of skin changes in GVHD (Grade I–IV).

^**Percentage of donor derived cells in peripheral blood of recipient in one or two separate measurements.

ND = not done.